Whereas TCEAL2 up-regulation was reported to associate with poor prognosis for serous ovarian cancer patients (26), TCEAL-1, 4, and 7 were reported to be down-regulated in different tumour types (27, 28, 29). This evidence concerns the gene TCEAL1 and ovarian serous adenocarcinoma.